Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

336 ARTÍCULOS , VIENDO DEL 1 AL 15

Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment

Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.

Neurobiol Aging. 2011 Jan;32(1):15-23. doi: 10.1016/j.neurobiolaging.2009.01.013. Epub 2009 Feb 27.

Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2011 Jul;32(7):1198-206. doi: 10.1016/j.neurobiolaging.2009.07.008. Epub 2009 Aug 14.

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment

Molinuevo JL, Berthier ML, Rami L.

Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):18-22. doi: 10.1016/j.archger.2009.11.004. Epub 2009 Nov 30.

Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies

Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV.

Neurobiol Aging. 2011 Oct;32(10):1733-41. doi: 10.1016/j.neurobiolaging.2009.11.008. Epub 2009 Dec 11.

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.

Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.

Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.

Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights

Mazza M, Marano G, Traversi G, Bria P, Mazza S.

J Alzheimers Dis. 2011;23(3):375-89. doi: 10.3233/JAD-2010-090700.

Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients

Keller C, Kadir A, Forsberg A, Porras O, Nordberg A.

J Alzheimers Dis. 2011;24(1):109-23. doi: 10.3233/JAD-2010-101290.

Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of asymptomatic giant cell arteritis in a patient with Alzheimer's disease

Kushida S, Akisaki T, Yasuda H, Moriyama H, Hara K, Nagata M, Taniguchi M, Urakami K, Yokono K, Sakurai T.

Geriatr Gerontol Int. 2011 Jan;11(1):114-8. doi: 10.1111/j.1447-0594.2010.00663.x.

Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population

Van Puyvelde K, Mets T; RODOS Study Group.

Geriatr Gerontol Int. 2011 Jul;11(3):256-61. doi: 10.1111/j.1447-0594.2010.00674.x. Epub 2011 Jan 4.

EEG and granular osmiophilic elements in early-onset Alzheimer's disease

Alberici A, Borroni B, Bonato C, Agosti C, Avanzi S, Santorelli FM, Simonati A, Padovani A.

Neurodegener Dis. 2011;8(4):259-61. doi: 10.1159/000322539. Epub 2011 Jan 7.

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

Schneider LS, Insel PS, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Jan;68(1):58-66. doi: 10.1001/archneurol.2010.343.

Alzheimer's disease and intelligence

Yeo RA, Arden R, Jung RE.

Curr Alzheimer Res. 2011 Jun;8(4):345-53. doi: 10.2174/156720511795745276.

In vivo human amyloid imaging

Sojkova J, Resnick SM.

Curr Alzheimer Res. 2011 Jun;8(4):366-72. doi: 10.2174/156720511795745375.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias